Art

J-GLOBAL ID：202102212132721405   Reference number：21A0168821

High platelet count as a poor prognostic factor for liver cancer patients without cirrhosis

肝硬変のない肝癌患者の予後不良因子としての高血小板数

Author (9)： Midorikawa Yutaka (Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.) ,  Takayama Tadatoshi (Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.) ,  Higaki Tokio (Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.) ,  Aramaki Osamu (Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.) ,  Teramoto Kenichi (Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.) ,  Yoshida Nao (Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.) ,  Tsuji Shingo (Genome Science Division, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo, Japan.) ,  Kanda Tatsuo (Department of Gastroenterology and Hepatology, Nihon University School of Medicine, Tokyo, Japan.) ,  Moriyama Mitsuhiko (Department of Gastroenterology and Hepatology, Nihon University School of Medicine, Tokyo, Japan.)
Material： BioScience Trends  (BST)
Volume： 14  Issue： 5  Page： 368-375(J-STAGE)  Publication year： 2020 
JST Material Number： L8367A  ISSN： 1881-7815  CODEN： BTIRCZ  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *hepatoma ,...
Semi thesaurus term： overall survival ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0168821&from=J-GLOBAL&jstjournalNo=L8367A") }}

Author keywords (5)： growth factor ,  hepatocellular carcinoma ,  platelet ,  portal hypertension ,  prognostic predictor

JST classification (2)： Tumors(=neoplasms)of digestive system  (GH04000D) ,  Surgical treatment for tumors  (GE03033T)

Reference (34)：

• 1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012; 379:1245-1255.
• 2. Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, Ramacciato G, Grazi GL, Pinna AD. Is portal hypertension a contraindication to hepatic resection? Ann Surg. 2009; 250:922-928.
• 3. Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, Imamura H, Sugawara Y, Kokudo N, Makuuchi M. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008; 134:1908-1916.
• 4. Ohkubo T, Midorikawa Y, Nakayama H, Moriguchi M, Aramaki O, Yamazaki S, Higaki T, Takayama T. Liver resection of hepatocellular carcinoma in patients with portal hypertension and multiple tumors. Hepatol Res. 2018; 48:433-441.
• 5. Lesurtel M, Clavien PA. Platelet-derived serotonin: translational implications for liver regeneration. Hepatology. 2014; 60:30-33.

Terms in the title (4)： 肝硬変 ,  癌患者 ,  予後不良因子 ,  血小板数